Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies. (Q46915626)
Jump to navigation
Jump to search
scientific article published on 29 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies. |
scientific article published on 29 September 2007 |
Statements
Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies (English)
Cédric Logé
Alexandra Testard
Olivier Lozach
Mélina Blairvacq
Jean-Michel Robert
29 September 2007